Document Detail


Safety of performing CT angiography in stroke patients treated with intravenous thrombolysis.
MedLine Citation:
PMID:  19965846     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Exposure to contrast agents may cause nephrotoxicity. The safety of performing CT angiography without having knowledge of the baseline creatinine level in stroke patients treated with tissue plasminogen activator (tPA) has not been established. METHODS: This is an observational cohort study, with a historical control group to evaluate the safety of CT angiography performed before tPA treatment given within 3 h of symptom onset. The CT angiography group represents all patients treated with tPA between September/2003 and November/2007 who had CT angiography. The control group consists of all patients treated with tPA between January 1999 and August 2003 when CT angiography was not performed. The primary outcome was a creatinine increase in 24-72 h compared with baseline; the secondary outcome was a creatinine increase by > or = 44 micromol/l in 24-72 h and the incidence of symptomatic intracerebral haemorrhage (sICH). RESULTS: Baseline parameters between the CT angiography group (164 patients, age 70+/-11; 91 male) and the control group (77 patients, age 67+/-11; 45 male) were similar. In the CT angiography group, the mean creatinine increase was -0.89 mmol/l and in the control group 2.2 mmol/l (p=0.42). A creatinine increase of > or = 44 micromol/l occurred in five patients (3%) in the CT angiography group and in three patients (4%) in the control group (p=0.50). Also, in the CT angiography group, eight patients (5%) had sICH as compared with three patients (4%) in the control group (p=0.73). CONCLUSION: Contrast agents given for CT angiography, performed in patients with normal and abnormal creatinine level, neither caused renal injury nor interfered with the safety of tPA treatment.
Authors:
P Aulicky; R Mikulík; D Goldemund; M Reif; M Dufek; T Kubelka
Related Documents :
9393466 - Spiral ct angiography: an alternative vascular evaluation technique for head and neck m...
15747576 - Ct angiography: principles, techniques and study optimization using 16-slice multidetec...
6393526 - Ct findings in acute renal infarction.
21886426 - Nucleus pulposus deformation following application of mechanical diagnosis and therapy:...
8210586 - Mr imaging of bone marrow edema pattern: transient osteoporosis, transient bone marrow ...
9393466 - Spiral ct angiography: an alternative vascular evaluation technique for head and neck m...
Publication Detail:
Type:  Journal Article     Date:  2009-12-03
Journal Detail:
Title:  Journal of neurology, neurosurgery, and psychiatry     Volume:  81     ISSN:  1468-330X     ISO Abbreviation:  J. Neurol. Neurosurg. Psychiatr.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-28     Completed Date:  2010-07-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985191R     Medline TA:  J Neurol Neurosurg Psychiatry     Country:  England    
Other Details:
Languages:  eng     Pagination:  783-7     Citation Subset:  IM    
Affiliation:
Department of Neurology, Masaryk University, St Anne's University Hospital, Pekarská 53, 656 91 Brno, Czech Republic.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Cerebral Angiography / adverse effects*
Cerebral Hemorrhage / epidemiology
Cohort Studies
Contrast Media / adverse effects
Creatinine / blood
Female
Fibrinolytic Agents / administration & dosage,  adverse effects,  therapeutic use*
Humans
Injections, Intravenous
Kidney Diseases / etiology*
Kidney Function Tests
Male
Middle Aged
Plasminogen Activators / therapeutic use
Retrospective Studies
Stroke / complications*,  mortality,  therapy*
Thrombolytic Therapy*
Tissue Plasminogen Activator / therapeutic use
Tomography, X-Ray Computed / adverse effects*
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Fibrinolytic Agents; 60-27-5/Creatinine; EC 3.4.21.-/Plasminogen Activators; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy.
Next Document:  Differential progression of brain atrophy in Parkinson disease with and without visual hallucination...